669 related articles for article (PubMed ID: 18589438)
1. Structure of the BH3 domains from the p53-inducible BH3-only proteins Noxa and Puma in complex with Mcl-1.
Day CL; Smits C; Fan FC; Lee EF; Fairlie WD; Hinds MG
J Mol Biol; 2008 Jul; 380(5):958-71. PubMed ID: 18589438
[TBL] [Abstract][Full Text] [Related]
2. Puma(*)Mcl-1 interaction is not sufficient to prevent rapid degradation of Mcl-1.
Mei Y; Du W; Yang Y; Wu M
Oncogene; 2005 Nov; 24(48):7224-37. PubMed ID: 16007132
[TBL] [Abstract][Full Text] [Related]
3. Vaccinia virus anti-apoptotic F1L is a novel Bcl-2-like domain-swapped dimer that binds a highly selective subset of BH3-containing death ligands.
Kvansakul M; Yang H; Fairlie WD; Czabotar PE; Fischer SF; Perugini MA; Huang DC; Colman PM
Cell Death Differ; 2008 Oct; 15(10):1564-71. PubMed ID: 18551131
[TBL] [Abstract][Full Text] [Related]
4. Structural plasticity underpins promiscuous binding of the prosurvival protein A1.
Smits C; Czabotar PE; Hinds MG; Day CL
Structure; 2008 May; 16(5):818-29. PubMed ID: 18462686
[TBL] [Abstract][Full Text] [Related]
5. Noxa induces apoptosis in oncogene-expressing cells through catch-and-release mechanism operating between Puma and Mcl-1.
Nakajima W; Tanaka N
Biochem Biophys Res Commun; 2011 Oct; 413(4):643-8. PubMed ID: 21945433
[TBL] [Abstract][Full Text] [Related]
6. (alpha/beta+alpha)-peptide antagonists of BH3 domain/Bcl-x(L) recognition: toward general strategies for foldamer-based inhibition of protein-protein interactions.
Sadowsky JD; Fairlie WD; Hadley EB; Lee HS; Umezawa N; Nikolovska-Coleska Z; Wang S; Huang DC; Tomita Y; Gellman SH
J Am Chem Soc; 2007 Jan; 129(1):139-54. PubMed ID: 17199293
[TBL] [Abstract][Full Text] [Related]
7. Nuclear magnetic resonance study of protein-protein interactions involving apoptosis regulator Diva (Boo) and the BH3 domain of proapoptotic Bcl-2 members.
Santiveri CM; Sborgi L; de Alba E
J Mol Recognit; 2012 Dec; 25(12):665-73. PubMed ID: 23192964
[TBL] [Abstract][Full Text] [Related]
8. Solution structure of prosurvival Mcl-1 and characterization of its binding by proapoptotic BH3-only ligands.
Day CL; Chen L; Richardson SJ; Harrison PJ; Huang DC; Hinds MG
J Biol Chem; 2005 Feb; 280(6):4738-44. PubMed ID: 15550399
[TBL] [Abstract][Full Text] [Related]
9. Structural insights into the degradation of Mcl-1 induced by BH3 domains.
Czabotar PE; Lee EF; van Delft MF; Day CL; Smith BJ; Huang DC; Fairlie WD; Hinds MG; Colman PM
Proc Natl Acad Sci U S A; 2007 Apr; 104(15):6217-22. PubMed ID: 17389404
[TBL] [Abstract][Full Text] [Related]
10. Identification of core structural residues in the sequentially diverse and structurally homologous Bcl-2 family of proteins.
Lama D; Sankararamakrishnan R
Biochemistry; 2010 Mar; 49(11):2574-84. PubMed ID: 20141168
[TBL] [Abstract][Full Text] [Related]
11. Membrane-insertion fragments of Bcl-xL, Bax, and Bid.
García-Sáez AJ; Mingarro I; Pérez-Payá E; Salgado J
Biochemistry; 2004 Aug; 43(34):10930-43. PubMed ID: 15323553
[TBL] [Abstract][Full Text] [Related]
12. In vitro binding properties of tumor suppressor p53 with PUMA and NOXA.
Park SY; Jeong MS; Jang SB
Biochem Biophys Res Commun; 2012 Apr; 420(2):350-6. PubMed ID: 22446329
[TBL] [Abstract][Full Text] [Related]
13. Interaction of a putative BH3 domain of clusterin with anti-apoptotic Bcl-2 family proteins as revealed by NMR spectroscopy.
Lee DH; Ha JH; Kim Y; Bae KH; Park JY; Choi WS; Yoon HS; Park SG; Park BC; Yi GS; Chi SW
Biochem Biophys Res Commun; 2011 May; 408(4):541-7. PubMed ID: 21527247
[TBL] [Abstract][Full Text] [Related]
14. Mouse Noxa uses only the C-terminal BH3-domain to inactivate Mcl-1.
Weber A; Ausländer D; Häcker G
Apoptosis; 2013 Sep; 18(9):1093-105. PubMed ID: 23733106
[TBL] [Abstract][Full Text] [Related]
15. NMR investigations of protein-carbohydrate interactions: studies on the relevance of Trp/Tyr variations in lectin binding sites as deduced from titration microcalorimetry and NMR studies on hevein domains. Determination of the NMR structure of the complex between pseudohevein and N,N',N"-triacetylchitotriose.
Asensio JL; Siebert HC; von Der Lieth CW; Laynez J; Bruix M; Soedjanaamadja UM; Beintema JJ; Cañada FJ; Gabius HJ; Jiménez-Barbero J
Proteins; 2000 Aug; 40(2):218-36. PubMed ID: 10842338
[TBL] [Abstract][Full Text] [Related]
16. Relationship between helix stability and binding affinities: molecular dynamics simulations of Bfl-1/A1-binding pro-apoptotic BH3 peptide helices in explicit solvent.
Modi V; Lama D; Sankararamakrishnan R
J Biomol Struct Dyn; 2013; 31(1):65-77. PubMed ID: 22803956
[TBL] [Abstract][Full Text] [Related]
17. Isolation of Bcl-2 binding proteins that exhibit homology with BAG-1 and suppressor of death domains protein.
Antoku K; Maser RS; Scully WJ; Delach SM; Johnson DE
Biochem Biophys Res Commun; 2001 Sep; 286(5):1003-10. PubMed ID: 11527400
[TBL] [Abstract][Full Text] [Related]
18. Divergence of Genbank and human tumor Bcl-2 sequences and implications for binding affinity to key apoptotic proteins.
Joseph MK; Solomon LR; Petros AM; Cai J; Simmer RL; Zhang H; Rosenberg S; Ng SC
Oncogene; 2004 Jan; 23(3):835-8. PubMed ID: 14737118
[TBL] [Abstract][Full Text] [Related]
19. A comparison of two strategies for affinity maturation of a BH3 peptide toward pro-survival Bcl-2 proteins.
Zhang S; Long A; Link AJ
ACS Synth Biol; 2012 Mar; 1(3):89-98. PubMed ID: 23651073
[TBL] [Abstract][Full Text] [Related]
20. A conserved hydrophobic core at Bcl-xL mediates its structural stability and binding affinity with BH3-domain peptide of pro-apoptotic protein.
Feng Y; Zhang L; Hu T; Shen X; Ding J; Chen K; Jiang H; Liu D
Arch Biochem Biophys; 2009 Apr; 484(1):46-54. PubMed ID: 19161970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
